At close: 2:05:40 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
1,400,180.00
1,712,214.00
1,447,311.00
802,640.00
Total Liabilities Net Minority Interest
90,453.00
106,092.00
80,324.00
59,141.00
Total Equity Gross Minority Interest
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Total Capitalization
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Common Stock Equity
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Capital Lease Obligations
23,244.00
26,963.00
28,367.00
11,604.00
Net Tangible Assets
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Working Capital
1,057,347.00
996,743.00
1,057,227.00
719,535.00
Invested Capital
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Tangible Book Value
1,309,727.00
1,606,122.00
1,366,987.00
743,499.00
Total Debt
23,244.00
26,963.00
28,367.00
11,604.00
Share Issued
65,804.36
64,967.88
58,471.10
39,376.10
Ordinary Shares Number
65,804.36
64,967.88
58,471.10
39,376.10
12/31/2020 - 6/12/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMMU.ST Mendus AB (publ)
8.85
+4.55%
OXBl.XC
7776.T CellSeed Inc.
408.00
-0.49%
BSLNz.XC
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
172.500
-3.42%
ALSEN.PA Sensorion SA
0.6100
-2.56%
2105.HK Laekna, Inc.
9.510
+5.55%
1952.HK Everest Medicines Limited
46.800
+0.65%
HNSA.ST Hansa Biopharma AB (publ)
38.00
-2.26%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1580
+1.28%